2016-04-05 CellProtect Nordic Pharmaceuticals AB participate in BIO-Europe Spring® 2016 in Stockholm Sweden. View presentation here.
2015-12-08 Karolinska University Hospital and CellProtect Nordic Pharmaceuticals AB are granted VINNOVA funding within the program for individual mobility to develop and tailor the apheresis technology to collection of starting materials for ATMPs.
2015-10-09 CellProtect Nordic Pharmaceuticals AB participate in the EU-funded, H2020, clinical trial of fetal mesenchymal stem cell treatment for congenital osteoporosis, the BOOSTB4 project.
2015-09-10 CellProtect Nordic Pharmaceuticals AB is presented at Nordic Life Science Days in Stockholm Sweden. See presentation here.
2015-06-23 The first patient treated in the Phase I/II (FIM) clinical trial in Multiple Myeloma with the innovative NK cell treatment, CellProtect with no serious events reported.
2015-04-15 The CEO of CellProtect Nordic Pharmaceuticals AB, Karin Mellström pitch CellProtect at the Karolinska Science Park day.
2014-10-15 Patent is granted in People’s Republic of China and U.S.A for NK cell expansion, large scale closed culturing system.
2014-09-19 First patient included, the first clinical batch of CellProtect is manufactured and stored frozen at Vecura, Karolinska University Hospital.
2015-09-17 CellProtect Nordic Pharmaceuticals AB has been granted SEK 500 000 in the framework of Vinnova’s program “Innovation in business” to establish the clinical development path for a conditional market approval for CellProtect. See Pressrelease here.
2013-10-02 MPA approves the significant amendment and the change of sponsor to the phase I/II clinical investigation of CellProtect.
2012-11-14 CellProtect Nordic Pharmaceuticals AB is approved and recognized as the sole commercial partner of 25 mkr VINNOVA consortium “Celltherapies”.
2012-05-30 CellProtect Nordic Pharmaceuticals AB is founded by 17 shareholders with a broad expertise in the field and acquire all assets and legal rights related to the CellProtect technology.
CellProtect in media
2014-10-06 i LifeScience Sweden: CellProtect går in i klinik
2012-12-12 i EpiFlemingsberg: Utmanar cancer med nya metoder